Teva Sells Additional $5.4B In Bonds To Buy Allergan Unit
Israeli drug giant Teva Pharmaceutical Industries Ltd. has tapped European bond markets to raise an additional $5.4 billion, atop a staggering $15 billion U.S. bond earlier this week, seizing favorable debt...To view the full article, register now.
Already a subscriber? Click here to view full article